Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Lintuzumab-Ac225 |
Trade Name | |
Synonyms | HuM195-Ac225|Actimab-A|Actinium Ac 225 Lintuzumab |
Drug Descriptions |
Lintuzumab-Ac225 is an anti-CD33 antibody in conjugation with a radioactive isotope (225Ac) that has anti-leukemia activity (PMID: 24857092). |
DrugClasses | CD33 Antibody 13 |
CAS Registry Number | 2209911-94-2 |
NCIT ID | C82414 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cytarabine + Lintuzumab-Ac225 | Cytarabine Lintuzumab-Ac225 | 0 | 0 |
Lintuzumab-Ac225 | Lintuzumab-Ac225 | 0 | 1 |